Cargando…
Outpatient parenteral antimicrobial therapy (OPAT) from an emergency model applied during the COVID-19 pandemic to standard of care: Preliminary lessons from our experience
OBJECTIVES: We wish to report on our experience of OPAT during the first two years of the COVID19 outbreak. PATIENTS AND METHODS: We recorded data on all patients treated in the OPAT regimen in 2020 and 2021 and compared overall trends, use of carbapenems and saved days of hospitalization. RESULTS:...
Autores principales: | Giuliano, G., Raffaelli, F., Faliero, D., Tamburrini, E., Tarantino, D., Nurchis, M.C., Scoppettuolo, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836987/ https://www.ncbi.nlm.nih.gov/pubmed/36642101 http://dx.doi.org/10.1016/j.idnow.2023.01.002 |
Ejemplares similares
-
OPAT: outpatient parenteral antimicrobial therapy
Publicado: (2020) -
Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
por: Tu, Jacky, et al.
Publicado: (2023) -
A broader view on outpatient parenteral antibiotic therapy (OPAT) stewardship
por: Hess, Danielle, et al.
Publicado: (2022) -
Outpatient parenteral antimicrobial therapy (OPAT) in patients with cystic fibrosis
por: Pedersen, Maya Graham, et al.
Publicado: (2015) -
Experiences in outpatient parenteral antimicrobial therapy (OPAT): Barriers and challenges from the front lines
por: Ng, Nicole, et al.
Publicado: (2021)